Table 2 Comparison of MLL-PTD and WT1 at the initial diagnosed and peri-transplant patients
|  | MLL-PTD > 0.08% (n/total tests, positive rate) | Median level of MLL-PTD > 0.08% (range, %) | Median level of MLL-PTD (range, %) | WT1 > 0.6% (n/total tests) | Median level of WT1 > 0.6% (range, %) | P value (MLL-PTD+ vs. WT1+) |
|---|---|---|---|---|---|---|
The initial diagnosis | 48/48(100%) | 30.30 (1.20-631.00) | 30.30 (1.20-631.00) | 44/47(93.6%) | 26.20 (0.82-83.20) | 0.233 |
Pre-transplantation | 37/48(68.8%) | 6.10 (0.10-414.10) | 1.70 (0.017-414.10) | 28/47(59.6%) | 6.20 (0.88-53.50) | 0.351 |
Post-transplantation | ||||||
  + 1 month | 8/43(18.6%) | 0.115 (0.083-0.73) | 0.046 (0.01-0.73) | 1/46(2.2%) | 0.82 | 0.027 |
  + 2 month | 12/44(27.3%) | 0.21 (0.09-0.82) | 0.047 (0-0.82) | 3/45(6.7%) | 0.86 (0.74-2.4) | 0.009 |
  + 3 montha | 13/45(28.9%) | 0.28 (0.086-104.70) | 0.05 (0-104.70) | 6/46(13.0%) | 1.50 (0.75-32.70) | 0.063 |
  + 4.5 montha | 8/38(21.1%) | 1.30 (0.082-55.30) | 0.0515 (0-55.30) | 9/39(23.1%) | 3.90 (0.81-44.10) | 0.524 |
  + 6 montha | 11/39(28.2%) | 1.40 (0.096-101.30) | 0.053 (0.015-101.30) | 12/39(30.8%) | 1.30 (0.60-80.90) | 0.500 |
  + 9 montha | 5/27(18.5%) | 0.09 (0.08-0.11) | 0.0445 (0-1.00) | 3/34(8.8%) | 0.71 (0.63-0.74) | 0.231 |
  + 12 month | 1/30(3.3%) | 0.45 | 0.049 (0-0.45) | 5/32(15.6%) | 0.88 (0.72-1.00) | 0.113 |